Tuesday, November 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

United Natural Foods Revises Fiscal Year 2024 Forecast

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Food Retailers Trading online
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

United Natural Foods has revised its fiscal year 2024 forecast on March 6, 2024. The company has narrowed its projected adjusted EPS range from $(0.88)-0.38 to $(0.56)-0.06 and its sales guidance from $30.90B-31.50B to $30.50B-31.00B. Additionally, adjustments have been made to the net loss, EPS, adjusted EBITDA, and capital expenditures outlook for the fiscal year ending August 3, 2024. These updates align with United Natural Foods’ current financial expectations for the upcoming period.

United Natural Foods, Inc. (UNFI) Stock Declines Slightly on March 6, 2024: What to Expect Next

On March 6, 2024, United Natural Foods, Inc. (UNFI) experienced a slight decline in its stock performance. According to data from CNN Money, UNFI is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be experiencing some downward pressure.

The price of UNFI shares decreased by $0.14 since the market last closed, representing a 0.93% drop. The stock closed at $14.87 on the previous trading day. However, there seems to be some positive movement in pre-market trading, as the stock has risen by $0.03.

Investors should keep an eye on UNFI’s stock performance in the coming days to see if the slight uptick in pre-market trading continues or if the stock experiences further declines. As always, it is important to consult with a financial advisor before making any investment decisions.

UNFI Stock Performance: Revenue Up, Net Income Down – March 6, 2024 Analysis

On March 6, 2024, United Natural Foods Inc. (UNFI) experienced mixed stock performances based on the latest financial data provided by CNN Money. The company reported a total revenue of $30.27 billion for the past year, which represents a 4.65% increase compared to the previous year. However, the total revenue remained flat at $7.55 billion for the first quarter of the current fiscal year.

UNFI also reported a net income of $24.00 million for the past year, showing a significant decrease of 90.32% compared to the previous year. On the other hand, the net income for the first quarter of the current fiscal year improved to -$39.00 million, indicating a 42.65% increase compared to the previous quarter.

Earnings per share (EPS) for UNFI stood at $0.40 for the past year, reflecting a 90.27% decrease compared to the previous year. However, the EPS improved to -$0.66 for the first quarter of the current fiscal year, showing a 42.74% increase compared to the previous quarter.

Overall, UNFI’s financial performance on March 6, 2024, showed a mixed picture. While the company experienced a slight increase in total revenue since last year, the net income and EPS figures exhibited significant declines. However, there was a notable improvement in net income and EPS compared to the previous quarter, indicating some positive momentum for the company.

Tags: UNFI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

Analyst Upgrades Target Stock with Optimistic Outlook

Finance_ stocks to buy

Trinity Capital Inc Announces Strong Financial Results for Q4 2023

Biopharmaceutical Markets and money (1)

Xeris Biopharma Holdings Reports Strong Fourth Quarter Financial Results

Recommended

Tesla Stock

Tesla’s AI Ambitions Fuel Bold Growth Forecast After Strong Earnings

1 month ago
Solana Stock

Solana’s Contradiction: Retail Fear Meets Institutional Greed

3 days ago
Northrop Grumman Stock

Defense Giant Northrop Grumman Surpasses Earnings Expectations

3 weeks ago
Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Coca-Cola Stock: A Dual-Pronged Growth Strategy Takes Shape

Institutional Investors Bet Big on Take-Two Ahead of GTA VI Launch

Cardano at a Crossroads: Key Developments That Could Shape ADA’s Path

Intel Shares Hold Steady Amidst Industrial Espionage Allegations

Amazon’s $50 Billion AI Gambit: A Strategic Power Play

Semiconductor Sector Surges as AI Demand Reshapes the Market

Trending

European Lithium Stock
Commodities

European Lithium Initiates Major Share Buyback Program

by Felix Baarz
November 25, 2025
0

In a decisive move to counter recent market pressures, European Lithium has launched an aggressive share repurchase...

Hims & Hers Stock

Hims & Hers Stock Surges on Potential Healthcare Policy Extension

November 25, 2025
Standard Lithium Stock

Standard Lithium Launches Aggressive Wall Street Outreach

November 25, 2025
Coca-Cola Stock

Coca-Cola Stock: A Dual-Pronged Growth Strategy Takes Shape

November 25, 2025
Take-Two Stock

Institutional Investors Bet Big on Take-Two Ahead of GTA VI Launch

November 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • European Lithium Initiates Major Share Buyback Program
  • Hims & Hers Stock Surges on Potential Healthcare Policy Extension
  • Standard Lithium Launches Aggressive Wall Street Outreach

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com